3/7/2014 8:47:52 AM 6 March 2014, London – Verona Pharma plc (AIM: VRP), the drug development company focused on “first-in-class” medicines to treat respiratory diseases, announces a Placing, Subscription and Open Offer of up to 637,324,831 New Ordinary Shares at 2.2...
Stay up-to-date with KAKE News: HUTCHINSON, Kan. — Growing up in Hutchinson, Maddie Page and Colton Harper have many fond memories of going to the Kansas State Fair. The cigarette smoke is not one of them. “We really love to go but if we could improve the...
In end-stage lung disease, transplantation is sometimes the only viable therapeutic option, but organ availability is limited and rejection presents an additional challenge. Innovative research efforts in the field of tissue regeneration, including pioneering...
Section Sponsored by: In 2010, reports about COPD awareness were of an ascending, thumbs-up variety. The public was starting to grasp what those four letters stood for — chronic obstructive pulmonary disease — particularly in light of their notoriety as...
Thursday, March 6, 2014 Serving Maine and Lincoln County for over a century. Volume 139 Issue 9 Current News Sports Features Letters Obituaries Subscribe Calendar Archives E-Edition News Police/Sheriff Courts Business Legal Notices Engagements,...
Albany, New York, USA (PRWEB) March 05, 2014 According to a new market report published by Transparency Market Research “Pulmonary Drug Delivery Systems Market (Products- Metered Dose Inhalers, Dry Powder Inhalers and Nebulizers; Applications- Asthma, COPD and Cystic...
RSS Error: A feed could not be found at `http://www.scoop.it/t/pulmonaryrehabnews/rss.xml`; the status code is `404` and content-type is `text/html;charset=UTF-8`
